All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32156815

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32156815	A319K	Env	Env	HIV Infections	G C L	View
2	32156815	A319T	Env	Env	HIV Infections	G C L	View
3	32156815	D322A	Env	Env	HIV Infections	G C L	View
4	32156815	D322R	Env	Env	HIV Infections	G C L	View
5	32156815	F317A	Env	Env	HIV Infections	G C L	View
6	32156815	F317L	Env	Env	HIV Infections	G C L	View
7	32156815	H308T	Env	Env	HIV Infections	G C L	View
8	32156815	I307T	Env	Env	HIV Infections	G C L	View
9	32156815	N160A	Env	Env	HIV Infections	G C L	View
10	32156815	N160K	Env	Env	HIV Infections	G R C L	View
11	32156815	N276Q	Env	Env	HIV Infections	D G R C L	View
12	32156815	N279A	Env	Env	HIV Infections	G R C L	View
13	32156815	N332A	Env	Env	HIV Infections	G R C L	View
14	32156815	N625A	gp120;gp41	Env	HIV Infections	D G R C L	View
15	32156815	T334A	Env	Env	HIV Infections	G C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.